Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy Black controls
Effect of nifedipine on changes in fibrinogen and von Willebrand factor in haemodialysis patients treated with recombinant human erythropoietin
Studies of possible mechanisms for the effect of urokinase therapy in small cell carcinoma of the lung
Long-term administration of heparin and heparin fractions and osteoporosis in experimental animals
Effect of repeated Aprosulate® and Enoxaparin® administration on tissue factor pathway inhibitor antigen levels
The use of recombinant factor VIIa in a patient with acquired haemophilia A undergoing surgery
Plasma thrombomodulin levels in coronary sinus blood in patients with coronary artery disease
The defence against free radicals protects endothelial cells from hyperglycaemia-induced plasminogen activator inhibitor 1 over-production
Three novel mutations in the protein C (PROC) gene causing venous thrombosis
Planned pregnancy and delivery in a patient with congenital afibrinogenaemia and heterozygous protein C deficiency
Oral contraceptive therapy causes an increased and not a decreased resistance to APC
Activated protein C
Statistica for Windows
GraphPad Prism™ Version 1.03
Hemostasis and Thrombosis
DIC Pathogenesis Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation
British Society for Haemostasis and Thrombosis, StAndrews
Improved haemocompatibility of artificial surfaces after coating with phosphorylcholine derivatives; and ex vivo human model using native flowing blood
An investigation into haemostatic changes in pulmonary blood during cardio-pulmonary bypass
The polymer coated drug-eluting stent
Rebleeding in a high shear system
Factor V Leiden as an independent risk factor for thrombosis in antithrombin deficiency type II
Interaction of factor V Leiden with inherited anti-thrombin deficiency
A comparison between functional and genetic testing for activated protein-C resistance (APCR)
Activated protein C resistance is not associated with thrombosis in myeloproliferative disorders
A novel FVIII gene inversion which causes severe haemophilia A
Thrombogenic mechanisms investigated with coagulation activation markers after infusion of factor IX concentrates in patients with haemophilia B
Amidolytic activity in Factor VIII concentrates and its relationship to lymphocyte function
Interferon treatment for chronic HCV infection in haemophiliacs
Fibrin D-dimer, von Willebrand factor and tissue plasminogen activator inhibitor antigens are predictive of major ischaemic heart disease
Angiotensin converting 1-enzyme polymorphism and ACE activity in subjects with cerebrovascular disease
Fibrinolytic markers in pregnancy
The effects of chronic smoking on the fibrinolytic potental of plasma and platelets
Peripheral arterial occlusive disease in patients with systemic sclerosis
Development of resistance to activated protein C during pregnancy
Gene mutations in twenty-six families with protein C deficiency
Antiphospholipid antibodies fail to modulate β2 glycoprotein-I inhibition of factor XII activation on triglyceride rich lipoproteins
Resistance to activated protein C in normal and complicated pregnancy
Affinity purified antiphospholipid antibodies bind normal term placenta
Previous thrombosis is a more useful predictor of future thrombosis than platelet surface activation antigens in myeloproliferative disorders
Use of the flow cytometer to measure platelet shape change and fibrinogen binding following platelet activation
A whole blood assay for platelet HPA1 (PLA1) phenotyping
Activated partial thromboplastin time is sensitive to mild factor XIC deficiency in the Coag-a-mate X2 coagulometer
Does propofol anaesthesia affect platelet aggregation?
Artificial joint cement reduces spontaneous platelet aggregation
Elevated levels of plasminogen activator inhibitor-1 (PAI-1), 4G/5G promoter polymorphism and the development of atherothrombotic and hemorrhagic stroke
The angiotensin-converting enzyme (ACE) gene I/D polymorphism and the association with plasma ACE levels in Pima Indians and Caucasian vascular disease patients
The influence of fibrin assembly on its subsequent lysis
Recognition of complexes of tissue plasminogen activator (t-PA) with C1-inhibitor and plasminogen activator inhibitor 1 by the LDL-receptor related protein (LRP)
Identification of the structural epitope recognized by a monoclonal antibody to antithrombin that blocks the action of its essential pentasaccharide
Thrombin-activatable plasminogen (TAPgen) augments the thrombolytic activity of tissue-type plasminogen activator
Activators and inhibitors of fibrinolysis in normal human bone marrow
Role of leukocytes in the suppression of fibrinolytic system in patients with septicaemia
Plasminogen activator inhibitor-1 activity and 4G/5G promoter polymorphism in Pima Indians with and without diabetes
Factor VII
Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism genotype and the relationship between PAI-1 activity levels and both glucose and triglyceride in non-insulin-dependent diabetes mellitus
A unique haemostatic defect in aortic valve stenosis
Platelet activation by Streptococcus sanguis is mediated by specific antibody and alternative complement pathway activation via the Fc receptor
A study of thrombi formed in the Chandler loop
Clinical validation of a chemiluminescence assay for the measurement of global antioxidant capacity of biological fluids
Should factor XII assays be included in thrombophilia screening?
A comparison of lyophilized artificially depleted plasmas and lyophilized plasmas from warfarin treated patients in correcting for coagulometer effects on international normalized ratios
The value of plasma calibrants in correcting coagulometer effects on international normalized ratios—an international multicentre study
The reliability of the mean normal prothrombin time (MNPT) of fresh plasmas and of the normal value from a lyophilized ‘normal’ plasma in prothrombin ratio determination
Cyclical blood flow variation and thrombus formation after stent insertion
Factor XII activation by artificial surfaces and its reduction by phosphorylcholine coatings
β2 Glycoprotein-1 levels and β2 glycoprotein-1 binding antibodies in patients with recurrent miscarriage
Inhibitors of phosphoprotein phosphatases modulate p42 mapk phosphorylation in endothelium
Comparison of direct thrombin inhibitors with low-molecular weight heparin in rabbit models of venous thrombosis and surgical blood loss
Platelet count and soluble P-selectin levels exhibit a circadian rhythm in healthy volunteers
E-Selectin as a predictor of restenosis following peripheral arterial angioplasty
Modelling the human thrombin-antithrombin complex
Activation of thrombin-activatable plasminogen (TAPgen) is enhanced by fibrin
Expression of platelet P-selectin varies with anticoagulant
The effect of freezing and freeze drying coumarinized plasma on international normalized ratios
The use of rFVIIa to treat a factor IX inhibitor following anaphylaxis with factor IX concentrate
Expression of factor VIII mRNA in liver cell lines is increased by interleukin-6
Management of childhood ITP—audit, guidelines and change in practice
Characterization of type 2N von Willebrand disease using molecular and phenotypic analysis
No evidence for neoantigen formation following terminal severe dry heat treatment of high purity clotting factor concentrates
Development of photo-affinity labelling reagents for the thrombin receptor
Heparin in standard doses does not suppress thrombin formation during cardiac surgery